- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04799886
Attitudes Associated to Prescription of ADHD Drugs Among Child and Adolescent Psychiatrists in Region Skåne.
Each year Region Skåne in Sweden gathers information on drug prescriptions within the region. The last ten years a significant pattern of uneven prescription rates of ADHD drugs to people up to 17 years of age are noticed in the different districts. These regional differences are noticed in other regions in Sweden as well and internationally.
The convention on the rights of the child became an institutional law in Sweden in 2020 and it emphasises that each child has the right to equal care and treatment. Therefore it is of importance to analyse how the variations in prescriptions rates arise and if we as healthcare providers can influence it. Our study is a collaboration between Region Skåne and the university of Lund and is a part of a larger study of the regional variations of prescriptions of ADHD drugs. Previous research informs us that a complex interplay of multiple factors can be behind variations in prescription rates among medical doctors and not the least subjective experiences and attitudes.
Our study performs semistructured interviews of Region Skånes child and adolescent psychiatrists with questions specifically regarding their own experiences and attitudes that might influence their prescription behavior.
The intention is to gather information that can guide future research questions.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Contact
- Name: DAVID SJÖSTRÖM, MD
- Phone Number: 0046739075390
- Email: sjostrom.david@gmail.com
Study Contact Backup
- Name: PEIK GUSTAFSSON, PHD
- Phone Number: 0046769250674
- Email: peik.gustafsson@med.lu.se
Study Locations
-
-
-
Malmö, Sweden, 20502
- Child and Adolescent Psychiatry, Region Skane
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- child and adolescent psychiatrist in Region Skåne
Exclusion Criteria:
- part of the research group
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Child and adolescent psychiatrist
|
Interviews are performed by one research group member and based on beforehand decided questions and sub-questions.
The interview material is transcribed and analysed on a theme level.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Attitudes and experiences associated with prescription and diagnosis of ADHD
Time Frame: 1 day (During the analysis of the transcribed interview)
|
Semistructured interview
|
1 day (During the analysis of the transcribed interview)
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Mykletun A, Widding-Havneraas T, Chaulagain A, Lyhmann I, Bjelland I, Halmoy A, Elwert F, Butterworth P, Markussen S, Zachrisson HD, Rypdal K. Causal modelling of variation in clinical practice and long-term outcomes of ADHD using Norwegian registry data: the ADHD controversy project. BMJ Open. 2021 Jan 19;11(1):e041698. doi: 10.1136/bmjopen-2020-041698.
- Zetts RM, Stoesz A, Garcia AM, Doctor JN, Gerber JS, Linder JA, Hyun DY. Primary care physicians' attitudes and perceptions towards antibiotic resistance and outpatient antibiotic stewardship in the USA: a qualitative study. BMJ Open. 2020 Jul 14;10(7):e034983. doi: 10.1136/bmjopen-2019-034983.
- Fulton BD, Scheffler RM, Hinshaw SP, Levine P, Stone S, Brown TT, Modrek S. National variation of ADHD diagnostic prevalence and medication use: health care providers and education policies. Psychiatr Serv. 2009 Aug;60(8):1075-83. doi: 10.1176/ps.2009.60.8.1075.
- Lindgren BM, Lundman B, Graneheim UH. Abstraction and interpretation during the qualitative content analysis process. Int J Nurs Stud. 2020 Aug;108:103632. doi: 10.1016/j.ijnurstu.2020.103632. Epub 2020 May 15.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- RSLUAFADHD2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ADHD - Combined Type
-
Haukeland University HospitalUniversity of BergenCompleted
-
Johns Hopkins UniversityRecruitingADHD - Combined TypeUnited States
-
BehandlingsskolerneUnknown
-
Children's Hospital Medical Center, CincinnatiNational Institute of Mental Health (NIMH)CompletedADHD - Combined Type | ADHD - Inattentive TypeUnited States
-
Haukeland University HospitalRecruitingADHD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - ImpulsiveNorway
-
Sync-Think, Inc.Sutter HealthUnknownADHD | ADHD Predominantly Inattentive Type | ADHD - Combined Type | ADHD, Predominantly Hyperactive - ImpulsiveUnited States
-
AccareCompletedBehavioral Symptoms | Problem Behavior | ADHD | Child Behavior Problem | ADHD Predominantly Inattentive Type | ADHD - Combined Type | Behavior Problem | Disruptive Behavior | Behavioral Problem | ADHD, Predominantly Hyperactive-Impulsive TypeNetherlands
-
Cingulate TherapeuticsRho, Inc.CompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder CombinedUnited States
-
Université du Québec a MontréalUniversité de Sherbrooke; Université de Montréal; Paris West University Nanterre...Completed
-
Cingulate TherapeuticsPremier Research Group plcActive, not recruitingADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder Combined | Attention Deficit Hyper Activity | Attention-deficit HyperactivityUnited States
Clinical Trials on Semi structured interview
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Multiple Sclerosis | Parkinson Disease | Rehabilitation | Neurologic Disorder | NeurosurgeryItaly
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Hospices Civils de LyonCompleted
-
University of OxfordCompletedCeliac Disease | Mental Health Wellness 1 | Emotional Problem | Stigma, Social | Celiac Disease in Children | Celiac | DisclosureUnited Kingdom
-
University Hospital, BordeauxCompleted
-
University Hospital, GrenobleNot yet recruitingSchizophrenia | Schizophrenia Schizoaffective
-
The Hong Kong Polytechnic UniversityRecruitingIntensive Care Units, PediatricHong Kong
-
Fondation Hôpital Saint-JosephRecruiting
-
Universitair Ziekenhuis BrusselVrije Universiteit BrusselNot yet recruiting
-
University Hospital, MontpellierRecruiting